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Laboratory animal models have provided valuable insight into foot-and-mouth disease virus
(FMDV) pathogenesis in epidemiologically important target species. While not perfect, these
models have delivered an accelerated time frame to characterize the immune responses in natural
hosts and a platform to evaluate therapeutics and vaccine candidates at a reduced cost. Further
expansion of these models in mice has allowed access to genetic mutations not available for
target species, providing a powerful and versatile experimental system to interrogate the immune
response to FMDV and to target more expensive studies in natural hosts. The purpose of this
review is to describe commonly used FMDV infection models in laboratory animals and to cite
examples of when these models have failed or successfully provided insight relevant for target
species, with an emphasis on natural and vaccine-induced immunity.
Introduction
Foot-and-mouth disease virus (FMDV: family Picorna-
viridae; genus Aphthovirus) is known to naturally infect a
wide variety of cloven-hoofed domesticated and wild
animal species, causing an acute disease characterized by
vesicular lesions of the tongue, snout, buccal cavity, feet
and teats (Grubman & Baxt, 2004). Despite causing
extensive lesions, the cycle of infection in the individual
animal is short, and foot-and-mouth disease (FMD)
usually resolves without the need for treatment and is
seldom lethal in adults (Arzt et al., 2011b). However, the
highly contagious nature, wide dissemination and signific-
ant economic impact of FMD have made it one of the most
feared livestock diseases and a major research focus for
more than a century. Progress towards the development of
effective tools for FMD control has been hampered by
several factors including the cost and logistics of large-
animal experimentation in specialized high-containment
facilities, incomplete knowledge of the host’s immune
systems and lack of immunological reagents compared to
biomedical rodent species and humans. These factors
delayed the production of vaccines on an industrial scale
and this major research goal was subsequently only
achieved in the 1950s (Lombard et al., 2007). In a review,
Brown (2003) highlighted that this milestone could not
have been achieved without certain significant advances in
our knowledge of FMD. The first significant advance was
the demonstration by Loeffler & Frosch (1897) that the
disease was caused by a virus and the second was the
establishment of FMD laboratory animal models, including
the guinea-pig model (Waldman & Pape, 1920) followed
by the suckling mouse model (Skinner, 1951). Although
not without their flaws, these FMD laboratory animal
models have helped elucidate several mechanisms of FMD
pathogenesis, which would have been difficult to achieve
directly in target species. These models have provided an
accelerated time frame at significantly reduced costs to
develop and test vaccine candidates and continue to be a
useful tool for interrogating FMDV immune responses.
However, we now know that porcine and ruminant immune
systems and responses to pathogens are significantly
different compared with laboratory animals and there are
occasions when prophylactic strategies proven effective in
FMD laboratory animal models have completely failed in
natural hosts. Although one could argue these failures
demonstrate the models are of limited value and FMDV data
generated in laboratory animals are controversial, these
scenarios have highlighted the gaps in our understanding
and may identify responses to FMDV and immune
mechanisms that are particular to natural hosts. There are
clear examples of data obtained from FMD laboratory
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animal models that have been extrapolated and applied to
target species. The goal of this review is to highlight the
strengths and limitations of FMD laboratory animal models,
focusing on natural and vaccine-induced immunity.
Historical overview of FMDV pathogenesis in laboratory
animals
As early as 1890, there were reports of FMDV-infected
animals that were not members of the order Artiodactyla
(as reviewed by Arkwright & Burbury, 1925). Rabbits in
stalls with FMDV-infected cattle were found to have oral
vesicles. The report by Waldman & Pape (1920) followed,
demonstrating that guinea pigs could be inoculated by
scarification on the planter surface of the metatarsus with
vesicular fluid from infected cattle. Challenged animals
developed generalized disease, including salivation, weight
loss and secondary vesicles on the fore-feet, tongue and
oral cavity. The disease was passaged successfully by
intracutaneous inoculation through 19 guinea pigs without
loss of virulence. Animals recovered from infection after
7 days and were immune from rechallenge with the same
strain (Arkwright & Burbury, 1925). These investigators
also reported that disease transmission from inoculated to
healthy guinea pigs did not occur, even when infected and
naive animals were placed in the same cage. Following the
demonstration of susceptibility in non-ungulate species,
a number of studies were performed to determine the
potential role of rats, mice, rabbits and birds in FMD
epidemiology. These animals can be experimentally infected
following parenteral challenge, with secondary mouth
or foot lesions reported in rats, rabbits and chickens
(Arkwright & Burbury, 1925; Beattie et al., 1928; Bedson
et al., 1927; Skinner, 1954). Contact infection was only
demonstrated in rabbits, and it is probable infection
occurred through existing skin abrasions (Beattie et al.,
1928). Therefore, depending on their susceptibility to
infection, animals can be divided into three categories: (i)
animals susceptible to FMDV infection which play a role in
the natural epidemiology of the disease, like cattle, sheep,
goats, pigs and African buffalo, (ii) animals susceptible to
FMDV infection that can play a role in the epidemiology but
only under some circumstances (for example capybaras,
deer, camels and a number of other animal species in the
order Artiodactyla) or (iii) animals susceptible to infection
only under experimental conditions that do not play a role
in the epidemiology of the disease; mice, guinea pigs and
rabbits belong to the last category (Alexandersen & Mowat,
2005; Gomes & Rosenberg, 1984).
It is clear that guinea pigs are the best laboratory animal to
model the pathogenesis of FMDV epithelial vesiculation (di
Girolamo et al., 1985). Similar to natural hosts, extensive
vesicles develop at the inoculation site within 24 h, the
vesicles rapidly rupture and the epithelium is desquamated.
Secondary vesicles develop on the tongue or mouth,
leading to salivation, food refusal and weight loss. Within
4 to 5 days, these vesicles begin to heal and desquamation
is completed in about 3 weeks (Knudsen et al., 1979).
Similar to the natural host, animals are pyrexic for a short
period and viraemia is cleared rapidly, coinciding with a
rapid antibody response, with serum neutralizing antibody
(SNA) titres detectable from 3 days post-infection (p.i.).
Mortality rates in guinea pigs are low, reported to be of the
order of 5 % (Arkwright & Burbury, 1925; Knudsen et al.,
1979). Due to the reproducibility of the FMDV response,
guinea pigs have been used extensively to produce anti-
serum, which has been used to develop sensitive diagnostic
and serotyping assays (Ferris, 1988). Guinea pigs have also
been used extensively for FMDV vaccine efficacy trials
(Cartwright et al., 1982; Guo et al., 2005; Yao et al., 2008).
It is noteworthy that natural FMDV isolates need to be
adapted to the guinea pig by serial injection in the footpad
(Aramburu, 1949; Knudsen et al., 1979). Although adap-
tation has been shown to alter viral antigenicity and
receptor recognition, guinea-pig-adapted virus can pro-
ductively infect natural hosts and kill suckling mice (Nu´n˜ez
et al., 2007). Similar to natural hosts, the guinea-pig model
is also limited by the lack of immune reagents, genetic
engineering and knockout technology.
Following the failure of earlier attempts to produce clinical
disease, the mouse as a model for FMDV was discounted
until the 1950s. During a series of experiments investi-
gating FMDV susceptibility of the cotton rat, Skinner
(1951) inoculated 3-week-old mice intracerebrally due to
the limited available stock of cotton rats. A large number of
mice surprisingly died, and Skinner went on to dem-
onstrate that unweaned mice 1 to 2 weeks old could be
infected intraperitoneally leading to a fatal infection char-
acterized by muscular paralysis and degenerative changes
in the myocardium and skeletal muscles (Platt, 1956;
Skinner, 1951; Subak-Sharpe et al., 1963). Clinical signs
included paralysis of the hindquarters, respiratory distress
within 24 to 48 h p.i. and death shortly thereafter. Sus-
ceptibility rapidly wanes with increasing age, and infection
in mice older than 3 weeks is typically subclinical (Campbell,
1970; Ferna´ndez et al., 1986; Skinner, 1951). Skinner’s report
is considered a major milestone in FMDV research as he
established a critical research tool for FMDV isolation and
titration, and for serum neutralization tests; the suckling
mouse model was eventually superseded by in vitro cell
culture systems (Skinner et al., 1952). It is now clear that
adult mice are also susceptible to experimental FMDV
infection. Following intraperitoneal (IP) challenge, virus
replicates primarily in the pancreas and, similar to target
species, the viraemic period is short, lasting between 48 and
72 h p.i. with production of SNA coinciding with viral
clearance (Borca et al., 1986; Charleston et al., 2011;
Ferna´ndez et al., 1986; Lefebvre et al., 2010). The exception
to this short period of virus replication is the ‘carrier state’,
which is considered unique to ruminants and is defined as
the period after 28 days p.i. in which infectious FMDV may
be detected in oesophageal–pharyngeal fluid (OPF) (OIE,
2012). FMD pathogenesis in adult mice is dependent on the
mouse strain, FMDV strain and, similar to the natural host
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(Arzt et al., 2014), the route of challenge (Table 1). C57BL/6
mice are the most susceptible common laboratory strain for
FMDV infection. These data are in agreement with our
unpublished results comparing the susceptibility of C57BL/6
and BALB/c mice to FMDV O UKG 34/2001 IP challenge.
C57BL/6 mice challenged with 103 TCID50 developed clear
signs of disease, including respiratory distress, neurological
signs and wasting; by comparison, no clear signs were
detected in BALB/c mice challenged with a higher dose of
106 TCID50 (unpublished data). The underlying reasons for
differences in susceptibility are not clear, but may be useful
to help determine the underlying genetic susceptibility or
resistance to FMDV in large animals. Infection of susceptible
mouse strains can lead to a lethal systemic infection in
adults, with virus replicating in all major organs, including
the heart, lung, brain, kidney, liver, spleen and thymus
(Salguero et al., 2005; Sanz-Ramos et al., 2008). FMDV has
also been shown to induce the formation of vesicles
following subcutaneous inoculation into the footpad of
susceptible mouse strains, with similar histological features
to those described in natural hosts (Salguero et al., 2005).
Similar to natural hosts, it is difficult to make a clear
judgement on the virulence of different FMDV serotypes in
mice due to the myriad FMDV strains. It is clear from the
literature that virulence is strain dependent. For example,
Garcı´a-Nu´n˜ez et al. (2010) demonstrated that FMDV A/Arg/
00 does not cause death in adult C57BL/6 mice even at 107
p.f.u.; by contrast, FMDV A/Arg/01 was lethal at doses as
low as 102 p.f.u. In cattle, FMDV A/Arg/00 showed only low
virulence; by contrast, FMDV A/Arg/01 caused severe
lesions and calf deaths. Therefore, field observations of
differences in virulence in target species were reproducible
in the adult mouse model (Garcı´a-Nu´n˜ez et al., 2010).
Consequently, the mouse model can provide data on strain
virulence to guide further experiments in cattle and may be a
useful tool to characterize new emerging FMDV strains in a
cost-effective manner.
The two common features of the FMDV mouse model that
warrant further review are viral replication in the
myocardium and pancreas, and their associated patholo-
gies (Fig. 1). Death in young livestock, documented in
calves, piglets and lambs, is a fairly common feature of
FMD epizootics (Alexandersen & Mowat, 2005). Generally,
the only gross pathological changes seen in these young
animals are in the myocardium and death is often
attributed to myocarditis (Donaldson et al., 1984;
Gulbahar et al., 2007). In addition, the rare manifestation
of FMDV-associated death in adults, known as ‘malignant
FMD’, is characterized by lesions and degeneration of the
myocardium (Arzt et al., 2011a; Shimshony et al., 1986).
Both viral myotropism, leading to direct cell injury, and the
immune response of the host are likely to play a role in the
pathogenesis of this syndrome. However, as reviewed by
Arzt et al. (2011a), there has been little specific investiga-
tion into this syndrome and the pathogenic mechanisms
remain unknown. There are clear age-related host factors
playing a role in FMD pathogenesis in the mouse as
susceptibility, characterized by muscular paralysis and
degenerative changes in the myocardium and skeletal
muscles, rapidly wanes with increasing age. The marked
myopathic affinity that FMDV has in young mice warrants
further investigation, as it may prove a useful model to
investigate age-related susceptibility and myotropism in
target species. In addition, myocarditis is a common
feature of FMDV infection in susceptible adult mice
(BALB/c mice; Fig. 1a) and dilated cardiomyopathy has
been reported as a common sequela in highly susceptible
C57BL/6 strains (Salguero et al., 2005). Age-related
susceptibility and myotropism have been described for
other viral infections in mice, the most studied being the
coxsackieviruses (CAVs). Like FMDV, CAV infection can
result in a marked myositis, with older mice seemingly
more resistant (Mclaren & Sanders, 1959). It has been
shown that certain CAVs utilize avb3 integrin as a receptor,
and that age-restricted expression of avb3 integrin on
skeletal muscle cells is likely responsible for murine CAV
age-related myotropism (Goldberg & Crowell, 1971;
Roivainen et al., 1994). Age-dependent receptor expression
by striated muscle cells may play a role in age-related
susceptibility of mice to FMDV, and indeed in other
animals. FMD experiments in adult mice may also provide
insight into the viral factors, host immune factors and
genetic susceptibility to malignant FMD in target species.
Similar to FMD pathogenesis in the mouse model,
myocarditis is reported to occur more frequently in target
species than indicated by case fatality alone, and may be a
common feature of FMDV infection (Korn & Potel, 1954).
The pancreas is considered the preferred site for FMDV
replication in adult mice; at 24 h p.i. the highest viral load
is in the pancreas (Bachrach, 1968; Ferna´ndez et al., 1986;
Sanz-Ramos et al., 2008). FMDV causes acute pancreatitis
in adult mice, affecting more severely the acinar tissue of
the exocrine pancreas (Sanz-Ramos et al., 2008). Severe
pancreatic injury is still clearly visible following clearance
of virus from the tissue at 21 days p.i., with histological
changes suggestive of progression to chronic pancreatitis
(Fig. 1). These changes include ablation of acinar cells,
vacuolization of the exocrine pancreas, cellular infiltration,
atrophy of the endocrine pancreas and fibrosis. Although
not demonstrated, these changes are likely to be associated
with loss of pancreatic function. Comparable pancreatic
pathology has been described during a lethal outbreak of
malignant FMD in gazelle (Berkowitz et al., 2010). It has
also been suggested that disruption of the pancreas
accounts for the biochemical changes reported for cattle
with heat-intolerance syndrome, a frequently reported
sequel to FMD in endemic settings (Arzt et al., 2011a;
Barasa et al., 2008; Catley et al., 2004; Ghanem & Abdel-
Hamid, 2010). Hyperglycaemia and hypoinsulinaemia have
been reported during the acute stages of FMD in cattle and
there are reports in cattle of FMDV causing pancreatic
necrosis (Manocchio, 1974; Nai, 1940; Yeotikar et al.,
2003). The unambiguous pancreatic tropism of FMDV in
the mouse model, combined with the available evidence for
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Table 1. Susceptibility of common laboratory mouse strains to FMDV infection
Mouse strain Age
(days)
Virus strain Virus
propagation
Range of
challenge
virus titre
Volume
inoculated
(ml)
Route of
infection
Minimum
lethal dose
(MLD)
Proportion
of deaths with
MLD (%)
Time of
first death
(days p.i.)
References
BALB/c 56–70 C1 C-S8c1 BHK-21 10–105 p.f.u. 100 Foot pad 103 p.f.u. 100 4 Salguero et al. (2005)
49–63 C1 C-S8c1 BHK-21 103 TCID50 100 IP 10
3 TCID50 90 – Kamstrup et al. (2006)
49–63 C1 Noville – 10–105 TCID50 100 IP None None None Lefebvre et al. (2010)
49–63 O1 Manisa 8/69 Calf kidney 10–105 TCID50 100 IP None None None Kamstrup et al. (2006);
Lefebvre et al. (2010)
49–63 Asia1 Shamir Calf kidney 10–105 TCID50 – IP None – 4 Lefebvre et al. (2010)
49–63 Asia1 Shamir 3/89 Calf kidney 103 TCID50 100 IP 10
3 TCID50 89 – Kamstrup et al. (2006)
49–63 A-22 Iraq 24/64 Calf kidney 103 TCID50 100 IP None None None Kamstrup et al. (2006)
49–63 SAT1 Bot 1/68 BHK-21 103 TCID50 100 IP 10
3 TCID50 50 1 Kamstrup et al. (2006)
49–63 SAT2 Zim 5/81 BHK-21 103 TCID50 100 IP 10
3 TCID50 60 – Kamstrup et al. (2006)
49–63 SAT3 Zim 4/81 BHK-21 103 TCID50 100 IP 10
3 TCID50 100 1 Kamstrup et al. (2006)
3–4 O OM III BALB/c suckling
mice
20–100
SMLD50
100 SC 20 SMLD50 100 (6/6) 2 Yang et al. (2008)
56–70 O1 Campos BHK-21 107.8 SMLD50 500 IP None None None Ferna´ndez et al. (1986)
C57BL/6 56–70 C1 C-S8c1 BHK-21 10–105 p.f.u. 50 Foot pad 105 p.f.u. 100 3 Salguero et al. (2005)
56–70 C1 C-S8c1 BHK-21 10–105 p.f.u. 100 IP 10 p.f.u. 100 2 Salguero et al. (2005)
56–70 C1 C-S8c1 MARLS BHK-21 10–105 p.f.u. 50 Foot pad None 100 None Salguero et al. (2005)
56–70 SAT1 BHK-21 10–105 p.f.u. 50 Foot pad 10 p.f.u. 100 2 Salguero et al. (2005)
56–70 A22 BHK-21 10–105 p.f.u. 50 Foot pad 103 p.f.u. 33 4 Salguero et al. (2005)
63–70 A/Arg/00 BHK-21 103–107 p.f.u. 100 IP None None None Garcı´a-Nu´n˜ez et al. (2010);
Molinari et al. (2010)
63–70 A/Arg/01 BHK-21 102–106 p.f.u. 100 IP 102 p.f.u. 100 2 Garcı´a-Nu´n˜ez et al. (2010);
Molinari et al. (2010)
CF-1 7 A/Arg/00 BHK-21 0.06–585 p.f.u. 50 IM 6 p.f.u. 10 6 Garcı´a-Nu´n˜ez et al. (2010)
7 A/Arg/01 BHK-21 0.03–333 p.f.u. 50 IM 3 p.f.u. 10 4 Garcı´a-Nu´n˜ez et al. (2010)
56–70 O1 Campos BHK-21 107.8 SMLD50 500 IP None None None Ferna´ndez et al. (1986)
SCID 21–28 C1 Noville – 10–105 TCID50 – IP 10 TCID50 100 (3/3) 4 Lefebvre et al. (2010)
21–28 O1 Manisa – 10–105 TCID50 100 IP None None None Lefebvre et al. (2010)
21–28 A22 – 10–105 TCID50 100 IP 10
2 TCID50 67 (2/3) 6 Lefebvre et al. (2010)
21–28 Asia1 Shamir – 10–105 TCID50 100 IP 10 TCID50 100 (3/3) 3 Lefebvre et al. (2010)
Swiss 56 C1 C-S8c1 BHK-21 105 p.f.u. 100 Foot pad 104 p.f.u. 30 4 Salguero et al. (2005)
3–7 O1 K BHK-21 700–76104
p.f.u.
100 IP 102 p.f.u. 72 2 (Rodrı´guez-Pulido et al.
(2011a)
56–70 O1 Campos BHK-21 107.8 SMLD50 500 IP None None None Ferna´ndez et al. (1986)
SJL/J 56–70 C1 C-S8c1 BHK-21 106 p.f.u. 100 Foot pad None None None Salguero et al. (2005)
BHK, Baby hamster kidney cells; IM, intramuscular; SC, subcutaneous; SMLD, suckling mouse lethal dose; –, no data.
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pancreatic pathology in target species, justifies additional
investigation of FMDV-induced pancreatitis. Exploring
viral and host mechanisms for FMDV-induced pancreatitis
is supported further by the potential contribution of this
pathology to chronic long-term metabolic sequelae of
FMD, which are major contributors to the impacts of FMD
upon livestock productivity (Barasa et al., 2008). There are
several aspects of FMDV pathogenesis in the mouse model
which are similar to those described in natural hosts. The
similarities described herein provide support for the mouse
as a model to investigate the role of host genetic factors and
viral factors involved in FMD pathogenesis. However, the
major contribution of the FMD mouse model has been an
improved understanding of the immune response.
Humoral immunity to FMDV infection and vaccination
The interaction of FMDV with the immune system of
target species remains incompletely understood, partly due
to the cost and logistics of large-animal experimentation
but mainly due to the paucity of immune reagents and
incomplete knowledge of their immune systems. Conse-
quently, laboratory animal models are an essential tool for
investigating viral and host factors that contribute to FMD
pathogenesis. In selecting a laboratory animal to model
FMDV immunity, a number of factors must first be
considered: animals must be susceptible to infection,
support viral replication and the immune response must
play an active role in controlling infection. Mice are the
most widely used laboratory animal to model FMDV
immune responses; the reasons for this are largely practical
in terms of cost, coupled with the availability of immune
reagents and our ability to manipulate mice genetically.
Although adult mice are not susceptible to natural infec-
tion and do not develop discernible FMD lesions, following
IP inoculation FMDV replication leads to viraemia and
elevated SNA titres (Borca et al., 1984; Ferna´ndez et al.,
1986). In addition, Borca et al. (1984) demonstrated that
immunity can be transferred by immune cells to immu-
nosuppressed mice, and viral clearance coincided with the
onset of SNA titres. These data confirm an active role of the
immune response and highlight the importance of humoral
immunity in the FMD murine model.
The significance of humoral immunity in controlling
FMDV infection is well documented and antibodies form
the major mechanism of protection (Loeffler & Frosch,
1897). It is also accepted that SNA titres determined by
using in vitro virus neutralization test (VNT) assays
correlate with protection in vaccinated livestock, although
exceptions do occur when protection predicted by VNT is
not observed, and vice versa (Doel, 1996). Natural infec-
tion induces a rapid and long-lived immunity in cattle that
is characterized by the maintenance of high titres of SNA,
for example up to 4.5 years (Cunliffe, 1964), and protec-
tion from challenge has been demonstrated up to 5.5 years
after initial infection (Garland, 1974). By contrast, current
inactivated vaccines induce a comparatively short duration
of immunity, with revaccination recommended at least
every 6 months (Doel, 1996). The precise reasons for this
discrepancy are unknown and understanding infection-
induced immunity in order to enhance vaccine-induced
immunity has been a major research target. The primary
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Fig. 1. (a) Striated ventricle muscle fibres of a
BALB/c mouse 1 day after IP challenge with
FMDV O UKG 34/2001. FMDV capsid (green)
is localized to cardiomyocytes [red, phalloidin;
blue, 49,6-diamidino-2-phenylindole (DAPI)].
(b) Pancreas of a C57BL/6 mouse 1 day after
IP challenge with FMDV O UKG 34/2001.
FMDV capsid (green) is detectable in the
pancreas [red, insulin (islets of Langerhans);
blue, DAPI]. No FMDV capsid was detected in
pancreas samples at 28 or 46 days post IP
challenge (data not shown). (c) Pancreas of a
C57BL/6 mouse 21 days post ovalbumin IP
inoculation. Routine haematoxylin and eosin (H
& E) stain demonstrates the normal morphol-
ogy of the pancreas: A, glandular acinar
cells of the exocrine pancreas; D, interlobular
duct; I, islets of Langerhans of the exocrine
pancreas; S, septa of the collagenous capsule.
(d) Pancreas of a C57BL/6 mouse 21 days
after IP challenge with FMDV O UKG 34/
2001. Routine H & E stain demonstrates the
chronic pathology following FMDV infection: A,
acinar cells; C, cellular infiltration; I, islets of
Langerhans. Bars: (a, b) 40 mm, (c, d) 100 mm.
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response to infection in cattle is characterized by serum
IgM detectable between 3 and 7 days post intradermolin-
gual challenge, reaching a peak between 5 and 14 days p.i.,
then slowly declining to an undetectable level by 56 days
p.i. Recently, Pega et al. (2013) demonstrated that the early
IgM response forms the major component of the in vitro
virus-neutralizing activity in cattle serum during the first
6 days p.i. However, isotype switching occurs rapidly with
specific IgG1 and IgG2 detected from 4 days p.i. and
reaching maximal levels from 14 days p.i. (Collen, 1994;
Doel, 2005; Juleff et al., 2009; Pega et al., 2013; Salt et al.,
1996). IgA is initially detected in serum and OPF from
7 days p.i., reaching a peak serum titre between 7 and
14 days p.i. (Collen, 1994; Doel, 2005; Salt et al., 1996). The
IgA titre in serum slowly declines from 14 days p.i. except
in ‘carriers’, where a significant second late response is
detected around 28 days p.i. In contrast to serum titres, a
second late IgA response is detected from 28 days p.i. in
OPF of all infected cattle independent of their ‘carrier
state’. Thereafter, the OPF IgA titre either declines to undetec-
table levels or persists in animals classified as ‘carriers’
(Parida et al., 2006; Salt et al., 1996). Virus-neutralizing
activities of both serum and OPF are higher in carrier than
non-carrier animals, consistent with continued immune
stimulation (McVicar & Sutmoller, 1974). Although similar
early B-cell responses have been reported in both contact-
and needle-challenged swine (Eble´ et al., 2007; Pacheco et al.,
2010b), the duration of immunity has been shown in some
cases to be short lived, with convalescent animals succumb-
ing to rechallenge 3 to 6 months after first exposure (Gomes,
1977; McKercher & Giordano, 1967) and it is generally
accepted that the duration of immunity in convalescent pigs
is significantly shorter than in cattle (Doel, 1996).
Vaccination protects cattle and pigs from the development
of clinical disease but not typically from subclinical
infection. Vaccination of cattle with FMDV antigen using
either oil or aluminium hydroxide/saponin formulations
is also characterized by a rapid antibody response, with
FMDV-specific IgM detected from 3 to 4 days post
vaccination (p.v.), IgG1 and IgG2 from 4 to 6 days p.v.
and SNA titres detected as early as 3 to 4 days p.v. (Abu
Elzein & Crowther, 1981; Carr et al., 2013). These data
are consistent with studies demonstrating protection from
challenge from 4 days post high-potency vaccination
(Barnett & Carabin, 2002). Similar to cattle, the onset of
immunity in pigs following high-potency oil-adjuvanted
emergency vaccination is surprisingly rapid and seems to
correlate with a rapid B-cell response (Eble´ et al., 2007;
Pacheco et al., 2010b) with protection from challenge as
early as 3 to 5 days p.v. (Barnard et al., 2005). Although the
antibody response to vaccination varies depending on the
antigen dose, quality and type of adjuvant used, there
appear to be consistent differences from the infection
response. Compared with the short-lived IgM responses
p.i., higher and longer-lasting serum IgM titres have been
reported for both cattle (80 days p.v.) and pigs (84 days
p.v.) (Abu Elzein & Crowther, 1981; Cox et al., 2003).
While infected cattle develop a rapid IgG and IgA response
in OPF, vaccinated cattle only develop an IgG response;
IgA is not detected after vaccination or even at subsequent
revaccination and low titres have only been detected
following multiple administrations (Francis et al., 1983;
Garland, 1974). In contrast to cattle, both serum and
salivary IgA can be detected in pigs from 7 days p.v., and a
correlation has been described between mucosal IgA titres
and protection against contact exposure in pigs (Eble´ et al.,
2007).
Similar to cattle and pigs, a rapid SNA response is elicited
by FMDV infection in mice. However, the response is more
comparable to cattle as high titres are maintained for
prolonged periods. Lo´pez et al. (1990) demonstrated high
titres maintained to 500 days post IP infection; the response
was protective as mice were resistant to rechallenge with
homologous virus. The antibody response to FMDV infec-
tion was first characterized in detail in mice, before reagents
were available for target species. There is still a lack of
reagents for a number of antibody isotypes in target species
and immunoglobulin genes are still being characterized in
livestock, especially for pigs, where the specificity of avail-
able reagents is a major concern (Pacheco et al., 2010b).
Following IP challenge of mice, FMDV-specific serum IgM
titres can be detected from 3 days p.i., IgG1 and IgG3 titres
from 7 days p.i. and IgG2a and IgG2b from 14 days p.i.
(Collen et al., 1989; Pe´rez Filgueira et al., 1995). IgG2b has
been shown to be the dominant IgG subclass in response to
IP challenge, followed by IgG1, IgG2a and IgG3, respectively
(Pe´rez Filgueira et al., 1995). Low serum IgA titres have been
reported; however, the mucosal FMDV immune response in
mice has not been described despite this region being the
most common site for primary virus replication in target
species (Pacheco et al., 2010a). As in natural hosts, FMD
vaccines prepared with inactivated virus and adjuvants
induce lower antibody titres which persist for less time than
those induced by live virus. Despite the short duration of
immunity, these vaccines are effective at protecting mice
against challenge with lethal doses of FMDV (Salguero et al.,
2005). The antibody isotype profile of mice in response to
vaccination is different from that in response to infection;
the response can also be altered by the vaccine formulation
or by addition of immune modulators to more closely
resemble the infection responses. Antibody responses of
mice immunized with conventional oil or aluminium
hydroxide formulated FMD vaccines are dominated by
either IgG1 or IgG2a, respectively, and these were the first
isotypes to be elicited in each case (Pe´rez Filgueira et al.,
1995). For both formulations, low titres of IgG2b were
transiently detected at 60 days p.v. Incorporating immune
modulators, for example lipopolysaccharides, enhanced the
antibody response, especially the IgG2b response, and
augmented resistance to viral challenge at 210 days p.v.
(Berinstein et al., 1991, 1993). FMDV-specific IgA has been
detected in saliva of subcutaneously vaccinated mice, a
response which can be enhanced by incorporating immune
modulators and which may merit further investigation due
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to the correlation of vaccine-induced mucosal IgA titres with
protection from challenge in pigs (Batista et al., 2010; Eble´
et al., 2007). Incorporating immune modulators signific-
antly elevated titres of the complement-fixing IgG2a and
2b subclasses and increased protection against challenge.
Of note, IgG1 titres were not significantly affected by
incorporating immune modulators (Batista et al., 2010).
In contrast to farm animals, there is extensive knowledge
on the regulation of antibody isotype switching by helper
T-cells in the murine immune response, the role of
cytokines in directing B-cell responses and the interactions
of antibodies with Fc receptors on different cell types
(Mosmann & Coffman, 1989). Antibody isotype profiles
are restricted by the nature of the antigen and by the form
in which the antigen is processed and presented to the
immune system; an understanding of this process is
important when considering the mechanism of immune
protection. Protective humoral immunity to pathogens is
contributed by distinct B-cell subsets with unique activa-
tion requirements and response signals. In the mouse, IL-4
preferentially induces class switching to IgG1 and trans-
forming growth factor b induces switching to IgG2b, the
predominant isotype generated in FMDV-infected mice. T-
helper 2 cells produce both of these cytokines and may play
a role in driving a T-dependent B-cell response dominated
by IgG2b and IgG1 (Hoyler et al., 2013). Rapid synthesis of
the complement-fixing IgG subclasses 2a, 2b and 3 would
agree with McCullough et al. (1992), who proposed that
effective protection is achieved through antibody-enhanced
phagocytosis of FMDV by cells of the reticuloendothelial
system. In addition, the early induction of isotype class
switching leading to FMDV-specific serum IgG1 and IgG3
by 7 days p.i. will drive the interaction of FMDV immune
complexes with the high affinity receptor FccRI expressed
on monocytes, macrophages and dendritic cells, modulat-
ing the adaptive immune response (van der Poel et al.,
2011). Vaccination studies in mice demonstrated that
immune modulators could enhance complement-fixing
IgG subclasses and augment resistance to virus challenge
(Batista et al., 2010; Pe´rez Filgueira et al., 1995). These data
provide support for complement-mediated phagocytosis
playing a significant role in viral clearance; however, no
direct correlation has been made between the different
antibody isotypes elicited and efficacy of protection
in FMD laboratory animal models or target species. It is
possible that immune mechanisms in the mouse model
leading to long-lasting humoral immunity are similar to
those in target species. A major drawback that must be
considered is the established IP route of challenge in the
mouse model. It is difficult to relate protection afforded by
vaccination in mice as challenge virus will interact with
different cell populations in the peritoneal cavity, which
may not reflect the natural challenge routes in target
species. In relation to antibodies and comparing cross-
species interactions with FMDV, it is now clear that bovine
antibodies have a number of unusual characteristics
compared with other vertebrates (Wang et al., 2013). The
unusual structure of the exceptionally long heavy-chain
complementary determining region 3 may allow bovine
antibodies to bind antigenic targets that are difficult for
mouse antibodies to access, such as channels and pores
(Wang et al., 2013). It is noteworthy that mouse
monoclonal antibodies have been used to identify antigenic
sites on the FMDV capsid and these sites are located on
structural protrusions on the virus surface, formed by
loops connecting b-barrel structures of the three outer
capsid proteins (Baxt et al., 1989; Kitson et al., 1990; Mateu
et al., 1990; Sanyal et al., 1997). Five neutralizing antigenic
sites on the capsid of serotype O FMDV have been mapped
using mouse monoclonal antibodies and the G-H loop of
VP1 was identified as immunodominant, and as a
consequence the G-H loop region has been a major target
for synthetic peptide vaccine studies (Crowther et al.,
1993). A significant component of the research on these
experimental vaccines was performed in mice and guinea
pigs; the peptide vaccines induced high titres of SNA and
protection from severe challenge infection in the FMDV
small laboratory animal models (as reviewed by Brown,
1992). However, the antibody response in cattle and pigs
was poor; the non-responsiveness was studied in inbred
mice and was overcome by incorporating T-helper cell
epitopes (Francis et al., 1987). These constructs performed
well in mice, guinea pigs and pigs, providing protection
from infectious challenge and high titres of SNA (Wang
et al., 2002). The difference between the response in these
species and the response reported in cattle is dramatic.
Vaccinated cattle developed antibodies to the peptide, as
determined by ELISA; however, the majority of animals
did not develop SNA titres as determined by VNT and all
animals developed clinical FMD upon challenge at 21 days
p.v. (Rodriguez et al., 2003). It is clear from large-scale
FMDV peptide vaccine studies in cattle that efficacy is
difficult to achieve (Taboga et al., 1997). One could specu-
late that differences in antibody responses in cattle com-
pared with other species are due to the structure of cattle
antibodies and how they interact with FMDV. Further
work is justified to explain these incongruous antibody
responses and to investigate antigenic sites on the FMDV
capsid which are recognized by antibodies from target
species.
Importance of cell-mediated immunity in response to
FMDV infection
A number of research groups have attempted to ascertain
the role of T-cells during FMDV infection and the majority
of these studies have been in mice. Borca et al. (1986) were
the first to describe a protective immune response in mice
that was independent of T-cells. Athymic nude mice, which
cannot generate mature T-cells, were challenged intraper-
itoneally and presented near-identical curves of viraemia,
SNA responses and tissue viral clearance compared with
those of their heterozygous littermates. These investigators
also demonstrated that adoptive transfer of enriched
splenic B-cells from previously challenged mice, harvested
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at 8 days p.i., aborted viraemia in irradiated recipients. By
contrast, adoptive transfer of enriched splenic T-cells from
immune donors was totally ineffective in protecting against
FMDV. The same laboratory demonstrated that the
prolonged immune memory following FMDV infection
in mice was not dependent on T-cells (Lo´pez et al., 1990).
Athymic mice and their euthymic littermates were FMDV
infected intraperitoneally; both groups showed a prolonged
SNA response up to 240 days p.i. and remained protected
against rechallenge. However, the kinetics of the SNA
response differed markedly between euthymic and athymic
mice. Both groups presented similar titres 8 days p.i.;
however, from 14 days p.i. the titres in athymic mice were
significantly lower and continued to decrease to 240 days
p.i. By contrast, the titres in euthymic mice continued to
increase from 14 to 240 days p.i. Athymic mice may
therefore have succumbed to higher titre challenge based
on the association between SNA titres and protection.
These data support a functional role for T-cells in main-
taining high titres of SNA in mice post FMDV infection,
yet T-cells were not essential for maintaining protective
immunity in this challenge model. Further support for T-
cells in the anti-FMDV antibody response is provided by
Collen et al. (1989), who demonstrated a significantly
lower frequency of FMDV-specific IgG antibody secreting
cells in the spleen of athymic mice compared with
euthymic mice during the first 12 days after intravenous
FMDV challenge. Interestingly, sera from both groups
contained similar FMDV-specific IgM, IgG2a, IgG2b, IgG3
and IgA titres at 7 and 10 days p.i.; however, IgG1 titres
were significantly lower at both time points in athymic
mice. These data suggest that isotype class switching in
response to FMDV infection can occur in the absence of T-
cells in mice. However, it must be recognized that low
numbers of functional T-cells have been demonstrated in
athymic nude mice and Collen et al. (1989) detected low
numbers of splenic T-cells in their athymic nude mice
(Ikehara et al., 1984).
Although the relevance of immune mechanisms in mice
which lead to rapid and protective FMDV antibody
responses to the situation in target species is unclear, they
have served to focus research efforts. Borca’s data
demonstrating that FMDV is a T-independent antigen in
mice, combined with a number of reports of no or very low
in vitro proliferation of peripheral blood T-cells despite the
development of high SNA titres in FMDV-challenged
cattle, led researches to question the role that T-cells play
(Doel, 1996). This role has been investigated recently in
cattle using subset-specific antibody depletion (Juleff et al.,
2009). Partial CD8+ T-cell depletion and complete WC1+
cd T-cell depletion had no discernible effect on the kinetics
of infection, clinical signs and immune response to FMDV.
The failure to achieve complete CD8+ depletion was not
unexpected as mAb-mediated depletion of these cells is
notoriously difficult; consequently, their role cannot
be described in target species using currently available
reagents (Naessens et al., 1998). Although FMDV-specific
MHC class I-restricted CD8+ T-cell responses have been
reported in infected or vaccinated cattle (Guzman et al.,
2008), data from the mouse model suggest these cells do
not play a major role, a conclusion supported by the partial
CD8+ depletion studies reported by Juleff et al. (2009),
and evidence of a role for cytolytic T-cells in the immune
response to FMDV is still lacking. In contrast to mice, cd
T-cells are considered a major T-lymphocyte population
in ruminants. It is noteworthy that WC2 cells, which
represent approximately 30 % of the mononuclear cell
population in bovine splenic red pulp, would not have
been affected by the WC1+ depletion protocol (Machugh
et al., 1997). Complete CD4+ T-cell depletion inhibited
antibody responses to a G-H loop peptide and non-
structural polyprotein 3ABC, but did not affect the rapid
isotype-switched SNA response, clinical response or virus
clearance (Juleff et al., 2009). Therefore, CD4+ T-cells do
not play a major role in the resolution of acute FMD in
cattle; however, other T-cell subsets may have contributed
to the response, including isotype class switching, and the
outcome might have been different if multiple T-cell
subsets were depleted simultaneously. In addition, deple-
tion was only temporary; therefore, the contribution of T-
cell-mediated responses to the maintenance of long-lived
serological memory, typically described in FMDV-infected
cattle, remains unclear.
The immune mechanisms leading to the rapid and
protective T-independent antibody response have been
investigated by Ostrowski et al. (2007) in mice. Both virus
localization and FMDV-mediated modulation of dendritic
cell (DC) functionality are reported to play a major role.
These investigators demonstrated in vitro that FMDV-
infected bone marrow-derived DCs (BMDCs) can directly
stimulate splenic marginal zone B-cells (CD9+ ‘innate B-
lymphocytes’) to secrete anti-FMDV IgM in a process
dependent on DC-derived IL-6 and B-cell-derived IL-10,
but independent of T-cells. However, T-cell help was
required to induce class switching to different IgG isotypes
in their in vitro model (Ostrowski et al., 2007). It is
noteworthy that both IL-10 and IL-6 have been shown to
promote innate-like B-lymphocyte proliferation and ter-
minal differentiation during the development of an
immune response against other pathogens (Montes et al.,
2006). IL-10 can also play an immunosuppressive role by
suppressing antigen-presenting cell (APC) and T-cell func-
tion by inhibiting chemokine secretion and MHC class II
expression (Pestka et al., 2004). Although Collen et al.
(1989) demonstrated isotype class switching in athymic
mice in response to FMDV infection, it is still not clear if
infection induces isotype class switching in vivo in the
complete absence of T-cells. Ostrowski et al. (2007) only
detected IgM isotype up to 6 days p.i. in athymic mice; by
contrast, IgG1 and IgG3 were detectable in euthymic mice
although titres were still low at this early time point and no
data were provided for later time points. These reports
provide further support for T-cell functions to achieve high
SNA titres and for long-lived IgG responses p.i. Similar
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T-cell dependency has been reported for other acute
cytopathic viral infections in mice, for example vesicular
stomatitis virus, where the production of neutralizing IgG
antibody is dependent on T-cells, while early infection is
characterized by a rapid T-independent neutralizing IgM
response (Ostrowski et al., 2007).
Interestingly, although FMDV infection of mouse BMDCs
is abortive, infected cells lose their ability to stimulate T-cells
and differentiate towards a macrophage-like phenotype
(Ostrowski et al., 2005). In fact, a generalized suppression of
T-dependent responses has been observed in vivo in mice
between 3 and 5 days p.i., thought to be mediated in part by
MHC class II and CD40 downregulation on DCs and by IL-
10 (Ostrowski et al., 2005). These results are supported
by Langellotti et al. (2012), who recently demonstrated in
mice that FMDV infection induces a reduction in splenic
plasmacytoid dendritic cells (pDCs) and conventional DCs
(CD11c+/CD8a+/2) and lymphocyte proliferation is inhib-
ited during early infection, with inhibition thought to be
associated with IFN-a induction. Significantly increased
levels of IFN-a protein were detected by ELISA in plasma of
FMDV-infected mice at 1 day p.i., with levels returning to
background by 3 days p.i. (Langellotti et al., 2012). Similar
to the mouse, FMDV infection of porcine pDCs, monocyte-
derived DCs (MODCs) and BMDCs is abortive (Guzylack-
Piriou et al., 2006; Harwood et al., 2008; Rigden et al., 2002).
Although porcine MODCs have been reported to respond in
vitro by increasing expression of MHC class II and CD86,
consistent with phenotype maturation, data generated in
vitro from cells derived from infected pigs are more
consistent with the suppressive responses described in vitro
and in vivo in mice (Summerfield et al., 2009). FMDV
infection impaired MODC function; infected cells produced
no IFN-c, less IFN-a and substantial amounts of IL-10, and
these investigators demonstrated that IL-10 was responsible
for in vitro T-cell inhibition (Diaz-San Segundo et al., 2009;
Nfon et al., 2008). Diaz-San Segundo et al. (2009) also
demonstrated significant amounts of IL-10 in serum of
FMDV-infected swine and proposed that a reduction of T-
cell activity by IL-10 may actually result in a more potent
induction of SNA and support T-independent antibody
responses. This hypothesis is consistent with the dependency
of the FMDV-innate B-cell response in mice on IL-10
(Ostrowski et al., 2005). The impairment of porcine MODC
function during FMDV infection in vitro is consistent with
reports in mice. In addition, the generalized suppression of
T-dependent responses in mice 3 to 5 days p.i. is consistent
with reports in swine that T-cell function is affected during
acute FMDV infection, characterized by T-cell unrespon-
siveness and lymphopenia (Bautista et al., 2003; Diaz-San
Segundo et al., 2006, 2009). Comparable to the mouse,
serum IFN-a protein is also detectable in pigs from 2 to
3 days p.i. and lymphopenia is reported to coincide with the
serum IFN-a response and peak viraemia (Nfon et al., 2010).
Similar to splenic pDC and conventional DC numbers in
infected mice, circulating pDC numbers in pigs transiently
decline during FMDV infection (Nfon et al., 2010). Porcine
pDCs are susceptible to FMDV infection, but only in the
presence of antibody and their response is characterized by
secretion of high levels of IFN-a (Guzylack-Piriou et al.,
2006). There is a report of FMDV, type C serotype,
productively infecting T- and B-cells resulting in lympho-
penia (Diaz-San Segundo et al., 2006); however, the rapid
recovery from lymphopenia in mice and swine is more
consistent with altered cell migration than cell loss and
subsequent repopulation (Golde et al., 2011). IFN-a could
play a role in the observed lymphopenia as type-I IFN has
been shown in mice to directly regulate lymphocyte
recirculation, leading to a transient blood lymphopenia
(Kamphuis et al., 2006). As described for mice, type-I IFN
may also promote B-cell responses and downregulate T-cell
responses. Nfon et al. (2010) also proposed that the short-
lived IFN-a response may contribute to the resolution of
FMDV viraemia prior to induction of specific immunity;
this hypothesis is supported by data on prophylactic
administration of IFN by adenovirus vectors, which rapidly
induces a FMDV-protective state in swine (Dias et al., 2011).
FMDV is highly sensitive to the effects induced by type-I
IFNs in vivo and in vitro (reviewed by Summerfield et al.,
2009). In addition to endosomal sensors of RNA in cells of
the immune system, for example DCs and toll-like receptors
(TLR) 3, 7 and 8, which are likely to play an important role,
it has been shown that IP inoculation of RNA transcripts
corresponding to FMDV S, IRES and 39-non-coding regions
can trigger type-I IFN in suckling mice and reduce their
susceptibility to subsequent infection (Rodrı´guez-Pulido
et al., 2011a, b). These results suggest the presence
of pathogen-associated molecular patterns in the FMDV
genome that are able to induce innate immunity in mice
leading to rapid antiviral responses involving type-I IFNs. Of
particular interest, it has been demonstrated recently in mice
that type-I IFN contributes to T-cell-independent antibody
responses to pathogens by promoting participation of
follicular B-cells and, therefore, enhancing the overall
magnitude of the antibody response to one that is class-
switched and dominated by IgG isotypes (Swanson et al.,
2010). Clearly, innate immunity can drive the humoral
immune response to pathogens, and the innate immune
response to FMDV remains a major knowledge gap
(Summerfield et al., 2009).
In contrast to data derived from mice and pigs, FMDV
infection of bovine MODCs is productive and infected cells
die, losing their ability to stimulate T-cell proliferation in vitro
(Robinson et al., 2011). One would expect these interactions
to lead to generalized suppression of T-dependent responses
and lymphopenia during acute infection in vivo, as reported
for mice and pigs. Yet this does not seem to be the case as
there are no reports of generalized immunosuppression
during the acute phase of FMDV infection in cattle (Windsor
et al., 2011). Compared with the significant levels of the
inhibitory cytokine IL-10 and serum IFN-a protein levels in
pigs and mice, only transient and low titres of biologically
active type-I IFN and IL-10 have been reported during acute
infection in cattle (Reid et al., 2011; Windsor et al., 2011). In
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addition, cattle did not develop leukopenia and proliferative
responses of peripheral blood mononuclear cells (PBMCs) to
either mitogen or third party antigen were not suppressed
(Windsor et al., 2011). However, as reported previously,
animals do not develop significant FMDV-specific T-cell
responses during the resolution of acute infection and up to
19 days p.i. (Garcia-Valcarcel et al., 1996; Windsor et al.,
2011). Robinson et al. (2011) proposed that the poor FMDV-
specific T-cell response during acute infection was the direct
result of FMDV immune-complex-mediated depletion of
APCs at sites of infection, leaving the animal able to respond
normally to third party antigens, consistent with no general-
ized immunosuppression (Windsor et al., 2011). The absence
of leukopenia and generalized immunosuppression may also
be associated with the comparatively low levels of type-I IFN
and IL-10 during acute infection in cattle. High levels of these
cytokines during acute infection could also explain the more
severe clinical signs generally described following FMDV
infection in pigs (Alexandersen et al., 2003). Interestingly,
the FMDV-specific T-cell proliferative response has been
reported to gradually increase from 28 days p.i. in cattle, a
response attributed to the carrier state and the presence of
persisting virus in ruminants (Collen, 1991). As proposed for
the mouse model, the T-independent immune response
leading to resolution of acute FMD may, therefore, be
followed by a T-dependent phase required for maintenance of
serological memory.
Importance of cell-mediated immunity in response to
FMDV vaccination
Compared to the immune response elicited by live virus,
the complexity of the response elicited by inactivated
vaccine virus preparations is far lower. Live FMDV induces
potent and long-lived systemic and mucosal antibody
responses due to its ability to replicate, deliver RNA to
endosomal compartments and initiate innate immune
responses (Zabel et al., 2013). Engineering vaccine formu-
lations to mimic natural infection could provide more
robust and long-lasting immunity, especially at mucosal
surfaces. However, present knowledge of immune responses
in target species offers little insight into the importance of
different T-cell subsets in the antiviral responses. In contrast
to infection, FMDV vaccination induces rapid T-cell
responses, and FMDV-specific CD4+ T-cell proliferation
has been detected in cattle as early as 7 days p.v. (Carr et al.,
2013; Doel, 1996). Similar results have been reported in
mice (Ostrowski et al., 2005) and inactivated FMDV has
been shown to increase CD8+ and regulatory T-cell
(CD4+CD25+Foxp3+) numbers in the spleen (Langellotti
et al., 2012). In addition, porcine cd T-cells have been shown
to proliferate and express cytokine and chemokine mRNA in
response to FMDV antigen in vitro, and similar proliferative
responses have been reported for bovine CD8+ and WC1+
cd T-cells, although CD4+ T-cells are the predominant
PBMC type that respond specifically to FMDV antigen in
vitro (Carr et al., 2013; Takamatsu et al., 2006). The
importance of T-cells in the FMD vaccine response was first
demonstrated in the mouse model. Piatti et al. (1991)
demonstrated by adoptive transfer of cells from FMDV-
antigen-immunized mice, that doses of B-cells 20 times
lower than those shown to be sufficient to abort viraemia
alone are effective when FMDV-primed T-cells are present.
Therefore, FMDV-specific T-cells can enhance anti-FMDV
B-cell responses when lower doses of antigen are adminis-
tered. Interestingly, T-cells sensitized with an unrelated T-
cell-dependent antigen, keyhole limpet haemocyanin, did
not enhance the response, suggesting the dependence is
antigen-specific (Piatti et al., 1991). The importance of
stimulating CD4+ T-cell responses in order to achieve
optimal antibody responses to vaccination has recently been
demonstrated in cattle (Carr et al., 2013). Depleting CD4+
T-cells significantly reduced SNA titres and delayed isotype
class switching to FMD-killed vaccines; therefore, in contrast
to the response to infection, CD4+ T-cells clearly fulfil an
important facilitator role. As reviewed recently by Golde
et al. (2011), a detailed knowledge of the antigenic regions
recognized not only by B-cells, but also by T-cells of target
species, is crucial to design novel vaccines to support
serological memory.
Similar to infection, FMDV-antigen localization and inter-
actions with DCs are likely to play a major role in the
protective immune responses induced by vaccination. As
demonstrated in mice, cattle and pigs, FMDV-infected DC
populations do not stimulate FMDV-specific T-cell proli-
feration; by contrast, DCs loaded with UV-inactivated
FMDV (UV-FMDV) stimulate a significant proliferative
response in vitro and can significantly boost antibody
responses in vivo when adoptively transferred to FMDV-
primed mice (Ostrowski et al., 2005; Robinson et al., 2011;
Summerfield et al., 2009). Similar to the results for FMDV-
infected DCs, Ostrowski et al. (2007) demonstrated in vitro
that UV-FMDV-loaded BMDCs could directly stimulate
splenic CD9+ B-cells. However, IgM was detected later at
7 days p.v. compared with 3 days p.i., and at significantly
lower titres. FMDV-infected BMDCs also stimulated IgG2a,
IgG2b and IgG3; by comparison, the only class-switched
isotype elicited by UV-FMDV was IgG2a (Ostrowski et al.,
2007). UV-FMDV also elicited IgM responses in splenocyte
cultures derived from athymic mice, but similar to the
response to infectious virus, no IgG subclasses were detected.
Therefore, in comparison to the response induced by FMDV-
infected BMDCs, DCs loaded with UV-FMDV are signific-
antly less efficient in directly stimulating innate CD9+ B-cells
to secrete T-independent antibodies and the delayed
response is typical of a T-dependent immune response.
The cytokine profiles were also distinct; UV-FMDV-loaded
mouse BMDCs did not induce IL-10 secretion upon co-
culture with splenocytes and secretion of IL-6 was signific-
antly lower than that by FMDV-infected BMDCs (Ostrowski
et al., 2005). Both of these cytokines were shown to be
essential in vitro for robust anti-FMDV antibody responses
and could in part explain the differences in kinetics,
magnitude and isotype profile of the antibody responses
(Ostrowski et al., 2007). By contrast, UV-FMDV-loaded
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BMDCs induced IL-2 secretion in vitro and IFN-c secretion
both in vivo and in vitro. Compared with IL-6 and IL-10,
neutralizing IFN-c in culture did not impair the secretion
of anti-FMDV antibodies (Ostrowski et al., 2005, 2007).
Contrary results have been reported for splenic CD11c+ cells
derived from mice 3 days after IP immunization with binary
ethyleneimine inactivated FMDV (BEI-FMDV) as used in
most current inactivated vaccines (Langellotti et al., 2012). In
contrast to reports by Ostrowski et al. (2005, 2007), BEI-
FMDV increased the production of the pro-inflammatory
cytokines IL-6, IL-10 and TNF-a while infection only
induced poor levels of IL-6 and IL-10 but significantly more
IFN-a. In fact, Langellotti et al. (2012) reported that BEI-
FMDV failed to stimulate T-cell proliferation and concluded
that BEI-FMDV induces a regulatory state that inhibits
effector mechanisms. This is in contrast to reports by
Ostrowski et al. (2005) that UV-FMDV improved the
functionality of BMDCs, favouring the development of
typical T-dependent responses. The reasons for these
discrepancies are not clear. It is noteworthy that FMDV
O1 Campos was used in both systems; however, different
methods were used for FMDV inactivation and the
investigators also isolated different DC populations. The
report by Ostrowski et al. (2005) is consistent with bovine
and porcine data that UV-FMDV-loaded DCs are highly
efficient APCs and that DC targeting could improve both T-
and B-cell responses to FMDV antigen (Robinson et al.,
2011; Summerfield et al., 2009). One could speculate the
results would have been different if BEI-FMDV was used as
opposed to UV-FMDV, as viral RNA remains mostly intact
following BEI-treatment (Brown, 2001) and the results in
target species would be more aligned to the regulatory
state reported by Langellotti et al. (2012). The conflicting
data generated in mice using UV-FMDV and BEI-FMDV
warrant further investigation.
As described previously in this review, immune modulators
can be incorporated into vaccine preparations to enhance
mucosal and circulating antibody responses in mice and
augmented resistance to FMDV challenge for long periods
(Berinstein et al., 1991, 1993). Targeting cells of the innate
immune system in order to induce rapid and long-lasting
protective immunity remains an active area of research.
Targeting innate immunity in combination with conven-
tional vaccination offers a means to achieve early cross-
serotype protection before onset of vaccine-induced adaptive
immunity. Based on in vitro and in vivo observations that
IFN is effective against FMDV, IFN-inducers were initially
tested in mice for their ability to induce innate protection
against FMDV. A single IP administration of poly I : C
was shown to protect suckling mice from lethal FMDV
challenge; protection was effective for 48 h after admin-
istration and survival correlated with serum IFN titres
(Richmond & Hamilton, 1969). These experiments were
extended to target species to test whether protection against
FMDV challenge could be similarly induced. Unexpectedly,
administering poly I : C intravenously to both cattle and
goats failed to offer any degree of protection against FMDV,
and similar results were reported following IP administra-
tion of poly I : C to pigs (Cunliffe et al., 1977; McVicar et al.,
1973). Therefore, data obtained from the mouse model were
considered of limited value and irrelevant for target species.
Despite this discouraging experience, the mouse model
demonstrated proof-of-principle that protection against
FMDV challenge could be achieved in vivo by stimulating
innate immune responses. Researchers continued to target
innate immune responses to induce rapid protection, and
success has been demonstrated recently following admin-
istration of adenovirus (Ad5) vectors expressing type-I or
type-III IFN to pigs (Dias et al., 2011; Perez-Martin et al.,
2014) and type-III IFN, but not type-I IFN, to cattle (Perez-
Martin et al., 2012). It is unclear why type-I IFN protected
pigs but did not protect cattle as pre-treatment of bovine cell
cultures with porcine or bovine IFN-a or -b inhibits FMDV
replication (Chinsangaram et al., 2001). Similar to many
other viruses, FMDV has developed mechanisms to anta-
gonize the IFN response, for example the viral proteases Lpro
and 3Cpro inhibit IFN production; however, type-I IFN is
readily detected in serum after FMDV infection in cattle,
pigs and mice (de los Santos et al., 2007; Wang et al., 2010,
2012). Recently 3Cpro has been shown to inhibit the IFN
signalling pathway by blocking STAT1/STAT2 nuclear
translocation and knockout mice, for example different
STAT deficient strains, may be valuable for identifying
innate signalling pathways relevant for FMDV pathogenesis
(Akira, 1999; Du et al., 2014). Recently, structural domains
predicted to enclose stable double-stranded RNA in the 59-
and 39-non-coding regions of the FMDV genome have been
shown to trigger type-I IFN in suckling mice (Rodrı´guez-
Pulido et al., 2011a). These RNAs were also able to induce an
antiviral state in porcine cells and reduce susceptibility to
challenge when administered intraperitoneally to suckling
mice. Recently, Venezuelan equine encephalitis virus empty
replicon particles (VRPs) have been shown to induce an
innate immune response that can protect C57BL/6 mice
from lethal FMDV challenge, a response dependent on a
functional type-I IFN system and IFN-c-inducible protein
10 (Diaz-San Segundo et al., 2013). Interestingly, Diaz-San
Segundo et al. (2013) demonstrated that VRPs induce a
more potent protective innate response in vitro than the Ad5
vector, which has been used as a vector for FMD vaccines
with variable results (Moraes et al., 2002). It will be
interesting to follow how these studies of the innate
response against FMDV translate to the target species, and
if they offer further support for the mouse model.
Duration of protective immunity
In contrast to infection, current inactivated FMD vaccines
formulated with adjuvant elicit short-lived protection in
target species and in laboratory animal models. Although
there are occasional exceptions, SNA titres correlate with
vaccine-induced protection in cattle, pigs and mice. The
mechanism for maintaining long-lived protective serolo-
gical immunity post viral infections remains a major
knowledge gap. As serum antibodies have a short half-life,
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reported to be less than 3 weeks in adult mice (Talbot &
Buchmeier, 1987; Vieira & Rajewsky, 1988), continual
replenishment is required either by long-lived plasma cells,
activation of memory B-cells to differentiate into plasma
cells or on-going recruitment and differentiation of naive
B-cells into antibody secreting plasma-blasts and plasma
cells to maintain protective humoral immunity (Wrammert
& Ahmed, 2008). Various mechanisms have been proposed
to explain the maintenance of serological immunity after
FMDV infection. These hypotheses include constant anti-
genic boost due to virus persistence in carrier animals,
induction of more efficient immune mechanisms during
infection compared with vaccination and quantitative dif-
ferences due to greater antigen mass after infection com-
pared with vaccination (Gebauer et al., 1988; Lo´pez et al.,
1990; Piatti et al., 1991). Although a laboratory animal
model for FMDV persistence has not been described, there
are data generated in the mouse that support the importance
of persisting virus or antigen to maintain serological
memory. Splenocytes from donor mice infected 135 days
previously, which were irradiated before cell transfer, were
shown to induce a strong anamnestic immune response in
FMDV pre-immunized recipient mice (Wigdorovitz et al.,
1997). Irradiation suppressed the transferred splenocytes so
any new anti-FMDV antibody detected in the new host must
have been produced by its own immune system. These
authors concluded that FMDV antigen present in the
irradiated cell population induced the anamnestic immune
response in the pre-sensitized recipients. No live virus could
be isolated from the transferred spleen cells and no viral
RNA was detected by reverse transcription PCR. The
response was dependent on donor cells presenting FMDV
epitopes and was MHC class II restricted and dependent on
recipient T-cell function. Similar anamnestic responses were
induced when splenocytes from 0.5 mg BEI-FMDV-immu-
nized donors were transferred 15 days p.v., but not at
30 days p.v. By comparison, splenocytes from donors
immunized with 30 mg BEI-FMDV did induce responses
at 30 days p.v., consistent with delayed antigen clearance at
higher antigen doses (Wigdorovitz et al., 1997). Lo´pez et al.
(1990) also reported that repeated transfer of splenocytes
from infected animals was able to induce antibody responses
against FMDV in normal recipients and protect against
challenge. These authors suggested that FMDV or antigen
may persist throughout life after infection in mice. These
data from the mouse model could be explained by the
observations in ruminants that virus particles are trapped by
follicular dendritic cells within the germinal centres (GCs)
of lymphoid tissue for long periods of time, potentially
stimulating the long-lasting immune responses character-
istic for FMDV infection (Juleff et al., 2008, 2012). One
could speculate that persisting virus or antigen, or
the establishment of the ‘carrier state’ could explain the
distinctive second late IgA responses and late T-cell
responses after 28 days p.i. in ruminants (Doel, 1996) and
a degree of antigen retention is crucial for serological
memory. FMDV retention in GCs has been reported in both
carrier and non-carrier ruminants and this condition may be
a common sequel to infection (Juleff et al., 2012). It is
unclear if these virus depots contribute to viral repopulation
and replication in other cells in the oropharynx, contrib-
uting to the ‘carrier state’. Further studies in natural hosts
and appropriate mouse models may answer these questions.
FMDV retention in GCs could explain the IgA response
detected from 28 days p.i. in OPF of all infected cattle
independent of their ‘carrier state’ and intermittent virus
replication may be required for the second late serum IgA
response described in carrier cattle (Parida et al., 2006; Salt
et al., 1996).
Piatti et al. (1991) demonstrated that the duration and
magnitude of the immune response in mice immunized
intraperitoneally with inactivated virus in PBS correlated
directly with the mass of antigen used, and at high antigen
doses there was no difference in the immune response
elicited or maintenance of SNA titres over 200 days
compared with experimental infection. Similar results were
reported by Lo´pez et al. (1990) and Wigdorovitz et al.
(1997). These data provide support for the hypothesis that
the amount of antigen in contact with the immune system
is responsible for the differences observed between vacci-
nation and infection. As yet, very little is known about the
FMDV plasma and memory B-cell responses in laboratory
animals or target species and the generation and mainten-
ance of serological memory remains a major knowledge
gap. Similar to natural hosts, experimental FMDV infec-
tion in mice is characterized by a short viraemic period,
rapid clearance of infectious virus and life-long serological
memory. Therefore, the mouse may be a suitable model to
identify mechanisms responsible for persistent antibody
responses to FMDV.
Conclusion
Several laboratory animal species have been used to model
FMD, each with their particular advantages and disadvan-
tages. Although clinical disease is less overt in mice
compared with other laboratory animals and data gener-
ated in the mouse are controversial and even contradictory
at times, these models have provided robust data to extend
our understanding of FMD in natural hosts. Arguably, the
major disadvantages of the FMD mouse model are the
unnatural routes of experimental infection or vaccination
and the uncertainty of the relevance for target species.
There is no doubt that data generated in laboratory animals
need to be assessed in the context of the target species.
However, interpreting data generated in the target species is
also complicated by the various different routes and
methods of experimental challenge. Therefore, data from
one natural host species are not always applicable to other
hosts. It is clear from this review that data generated in the
mouse can often be reconciled with available data from
target species and the models have successfully predicted
immune responses to FMDV in cattle and pigs. Significant
knowledge gaps remain in our understanding of FMD
pathogenesis, and even basic knowledge of the development
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of anti-FMDV antibody responses contains substantial gaps
(Arzt et al., 2011a, b). The following FMD knowledge gaps
will benefit from research in small laboratory animals:
1. What are the mechanisms for maintaining serological
memory to FMDV?
2. What are the mechanisms of virus neutralization in vivo,
what is the role of different antibody isotypes and what role
do subneutralizing or non-neutralizing antibodies play?
3. Besides DCs and B-cells, what is the role of other cell
types at various stages of infection?
4. What other factors besides virus binding and entry are
responsible for cellular susceptibility?
5. What are the determinants of tissue tropism beyond
integrins, and what innate and adaptive factors contribute
to tropism?
6. What factors are responsible for genetic resistance to
FMDV infection?
7. What factors are responsible for age-dependent suscept-
ibility to FMDV infection?
8. Which other innate immune factors are essential for a
protective response to FMDV infection?
9. What are the virus and host factors responsible for
malignant FMD and viral myotropism?
10. What processes are responsible for long-term metabolic
disturbances associated with FMDV infection, for example
heat-intolerance syndrome?
Although data from these studies are unlikely to be
conclusive, they will undoubtedly provide preliminary data
to direct studies in target species and will add substantial
basic science value by improving understanding of viral
infections.
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